Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-T.
- DOI
- 10.1155/proc/9766669
- Published
- 2025
- Container
- Prostate cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1155/proc/9766669,
title = {Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-T.},
author = {Shore ND and Antonarakis ES and Hafron J and Moses KA and Pieczonka C and Lowentritt B and Sheikh N and George DJ and Dorff TB},
year = {2025},
journal = {Prostate cancer},
doi = {10.1155/proc/9766669},
url = {https://doi.org/10.1155/proc/9766669}
}RIS
TY - JOUR TI - Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-T. AU - Shore ND AU - Antonarakis ES AU - Hafron J AU - Moses KA AU - Pieczonka C AU - Lowentritt B AU - Sheikh N AU - George DJ AU - Dorff TB PY - 2025 JO - Prostate cancer DO - 10.1155/proc/9766669 UR - https://doi.org/10.1155/proc/9766669 ER -
APA
ND, S., ES, A., J, H., KA, M., C, P., B, L., N, S., DJ, G., & TB, D. (2025). Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-T.. Prostate cancer. https://doi.org/10.1155/proc/9766669
Source records
- pubmed · retrieved 2026-09-27T09:47:57.830Z